| scholarly article | Q13442814 |
| P2093 | author name string | Yong Cheng | |
| Xiaojun Ding | |||
| Yang Sun | |||
| Hong Ruan | |||
| Youcheng Yu | |||
| Zhijian Sang | |||
| P2860 | cites work | Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database | Q44849577 |
| Valproic acid in normal therapeutic concentration has no neuroprotective or differentiation influencing effects on long term expanded murine neural stem cells | Q45205029 | ||
| Valproic acid induces differentiation of a supratentorial primitive neuroectodermal tumor | Q45288673 | ||
| Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cells | Q47589926 | ||
| Microinjection of valproic acid into the ventrolateral orbital cortex exerts an antidepressant-like effect in the rat forced swim test | Q48888799 | ||
| Effect of trichostatin A on cell growth and expression of cell cycle- and apoptosis-related molecules in human gastric and oral carcinoma cell lines | Q54028710 | ||
| Decreased histone deacetylase activity in chronic obstructive pulmonary disease | Q54664094 | ||
| Proliferative activity in periapical lesions | Q73448632 | ||
| Important role of SUMOylation of Spliceosome factors in prostate cancer cells | Q87401469 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Structural and functional characterization of the phosphorylation-dependent interaction between PML and SUMO1 | Q27696842 | ||
| Mechanisms, regulation and consequences of protein SUMOylation | Q27865251 | ||
| Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo | Q28485252 | ||
| Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma | Q33856474 | ||
| Valproic acid induces differentiation and transient tumor regression, but spares leukemia-initiating activity in mouse models of APL. | Q34254302 | ||
| Control of cardiac growth by histone acetylation/deacetylation | Q34482206 | ||
| Microinjection of Valproic Acid into the Ventrolateral Orbital Cortex Enhances Stress-Related Memory Formation | Q34542172 | ||
| Expression of FACT in mammalian tissues suggests its role in maintaining of undifferentiated state of cells | Q35640168 | ||
| Valproate Inhibits Methamphetamine Induced Hyperactivity via Glycogen Synthase Kinase 3β Signaling in the Nucleus Accumbens Core | Q35647946 | ||
| Acetylation of H2A.Z is a key epigenetic modification associated with gene deregulation and epigenetic remodeling in cancer | Q35694399 | ||
| NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells | Q35850681 | ||
| Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells | Q36700778 | ||
| Overexpression of SENP3 in oral squamous cell carcinoma and its association with differentiation | Q36858606 | ||
| Histone deacetylase inhibitors: molecular mechanisms of action | Q36908440 | ||
| Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia/lymphoma | Q37042173 | ||
| Chromatin-remodelling mechanisms in cancer. | Q37134923 | ||
| Senp1 is essential for desumoylating Sumo1-modified proteins but dispensable for Sumo2 and Sumo3 deconjugation in the mouse embryo | Q37178230 | ||
| DeSUMOylating enzymes--SENPs | Q37230112 | ||
| Identification and Characterization of a New Chemotype of Noncovalent SENP Inhibitors | Q37341772 | ||
| SUMO playing tag with ubiquitin | Q37948388 | ||
| Dynamically regulated sumoylation of HDAC2 controls p53 deacetylation and restricts apoptosis following genotoxic stress | Q39366270 | ||
| An acetylation switch regulates SUMO-dependent protein interaction networks. | Q39502343 | ||
| Valproic acid: growth inhibition of head and neck cancer by induction of terminal differentiation and senescence. | Q39570650 | ||
| Overexpression of small ubiquitin-related modifier-1 and sumoylated Mdm2 in oral squamous cell carcinoma: possible involvement in tumor proliferation and prognosis. | Q40098999 | ||
| Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells | Q40153779 | ||
| Long-term efficacy of valproate versus lamotrigine in treatment of idiopathic generalized epilepsies in children and adolescents | Q43157409 | ||
| Overexpression of SENP5 in oral squamous cell carcinoma and its association with differentiation | Q43725106 | ||
| Valproate recovers the inhibitory effect of dexamethasone on the proliferation of the adult dentate gyrus-derived neural precursor cells via GSK-3β and β-catenin pathway | Q44495925 | ||
| P433 | issue | 6 | |
| P921 | main subject | protein sumoylation | Q3503705 |
| oral squamous cell carcinoma | Q18553522 | ||
| P304 | page(s) | 3979-3987 | |
| P577 | publication date | 2016-11-15 | |
| P1433 | published in | Experimental and Therapeutic Medicine | Q23979083 |
| P1476 | title | Anticancer effects of valproic acid on oral squamous cell carcinoma via SUMOylation in vivo and in vitro | |
| P478 | volume | 12 |
| Q92598876 | DynOVis: a web tool to study dynamic perturbations for capturing dose-over-time effects in biological networks |
| Q89701153 | GANT61 and Valproic Acid Synergistically Inhibited Multiple Myeloma Cell Proliferation via Hedgehog Signaling Pathway |
| Q47100939 | HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cells |
| Q47136713 | The role and possible molecular mechanism of valproic acid in the growth of MCF-7 breast cancer cells. |
Search more.